|
| Press Releases |
|
 |
|
| Thursday, October 17, 2024 |
|
|
Athos宣佈其人工智慧生成的全新口服G9A抑製劑ATH-063的I期臨床試驗頂線數據，顯示其對強效抗炎調節性T細胞的選擇性擴增和啟動 |
| Athos Therapeutics, Inc.（“Athos”），一家處於臨床階段的生物技術公司，致力於為免疫介導疾病患者開發精準的小分子療法，今天宣布了公司I期臨床試驗的頂線結果。該試驗涉及ATH-063，這是一種正在開發中的口服小分子G9A抑制劑，也是公司為治療炎症性腸病（IBD）開發的主要資產。 more info >> |
|
|
Athos宣布其人工智能生成的全新口服G9A抑制剂ATH-063的I期临床试验顶线数据，显示其对强效抗炎调节性T细胞的选择性扩增和激活 |
| Athos Therapeutics, Inc.（“Athos”），一家处于临床阶段的生物技术公司，致力于为免疫介导疾病患者开发精准的小分子疗法，今天宣布了公司I期临床试验的顶线结果。该试验涉及ATH-063，这是一种正在开发中的口服小分子G9A抑制剂，也是公司为治疗炎症性肠病（IBD）开发的主要资产。 more info >> |
|
|
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells |
| Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of precision small molecule therapeutics for patients with immune-mediated diseases, today announced topline results for the company's Phase 1 clinical trial of ATH-063, an investigational oral small molecule G9A inhibitor and the company's lead asset in development for the treatment of inflammatory bowel disease (IBD). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
MHI Thermal Systems Receives Order for Large-scale Centrifugal Chillers from Empower for its District Cooling Plants in Dubai, UAE
Oct 18, 2024 11:20 JST
|
|
|
富士通と帝京大学がXRや空間コンピューティング、生成AIを活用し、生活習慣改善を促進するUXの共同研究を開始
Oct 18, 2024 10:20: JST
|
|
|
Fujitsu and Teikyo University begin joint research on UX platform for promotion of lifestyle improvement using XR, spatial computing, and generative AI
Oct 18, 2024 10:38 JST
|
|
|
达势股份-達美樂中國收益和利潤雙雙增長 持續優化投資者結構
Oct 18, 2024 07:00 HKT/SGT
|
|
|
达势股份-达美乐中国收益和利润双双增长 持续优化投资者结构
Oct 18, 2024 07:00 HKT/SGT
|
|
|
DPC Dash - Domino's Pizza China Drives Sales and Profit Growth and Optimizes Shareholder Structure
Oct 18, 2024 07:00 HKT/SGT
|
|
|
TANAKA to Provide Medals Representing the Event Concept with a Design of Gently Curved Circular Expansion for the Tokyo Legacy Half Marathon 2024
Oct 18, 2024 3:00 JST
|
|
|
Participation in the Multilateral System Remains High as Performance Drops, New Index Finds
Oct 18, 2024 01:00 HKT/SGT
|
|
|
Join the Top 1% of Web3: VAP Group Presents Global Blockchain Show in Dubai
Oct 17, 2024 23:00 HKT/SGT
|
|
|
Learn & Get Inspired at the Global STEM Confex
Oct 17, 2024 22:26 HKT/SGT
|
|
|
Moolec Has Received USDA Approval for the First Genetically Modified Pea in History
Oct 17, 2024 22:00 HKT/SGT
|
|
|
Embracing the Future of Manufacturing with the 26th Edition of the South Africa Manufacturing Show
Oct 17, 2024 22:00 HKT/SGT
|
|
|
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells
Oct 17, 2024 21:00 HKT/SGT
|
|
|
GTJAI Signed the Good Employer Charter Again
Oct 17, 2024 19:43 HKT/SGT
|
|
|
國泰君安國際再次簽署《好僱主約章》 營造和諧共融工作環境
Oct 17, 2024 19:30 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
